Literature DB >> 27070809

Design and demonstration of a pumpless 14 compartment microphysiological system.

Paula G Miller1, Michael L Shuler2.   

Abstract

We describe a human "Body-on-a-chip" device (or microphysiological system) that could be used to emulate drug distribution, metabolism, and action in the body. It is based upon a physiologically based pharmacokinetic-pharmacodynamic (PBPK-PD) model, where multiple chambers representing different organs are connected with fluidic channels to mimic multi-organ interactions within the body. Here we describe a pumpless 14 chamber (13 organs) microfluidic cell culture device that provides a separation between barrier and nonbarrier types of cell cultures. Our barrier chamber layer (skin, GI tract, and lung) allows for direct access and/or exposures to chemical or biological reagents forcing these reagents to pass through a barrier of cells established on a microfabricated membrane before exposing the nonbarrier tissue chambers (fat, kidney, heart, adrenal glands, liver, spleen, pancreas, bone marrow, brain, muscle) or entering the microfluidic circulation within the device. Our nonbarrier tissue chambers were created as three-dimensional configurations by resuspending cells in hydrogel (PGMatrix). We used cell lines to represent five of these organs (barrier lines-A549 [lung] and Caco2 [GI]) (nonbarrier lines-HepG2 C3A [liver], Meg01 [bone marrow], and HK2 [kidney]). The dimensions of our straight duct-like channels to each organ chamber were designed to provide the appropriate flow of a culture medium. The organ volumes and organ flow rates that have been reported for an average human male were used to estimate the desired fluid retention times in each organ chamber. The flow through the channels was induced by gravity on a custom programmed rocker platform which enabled pumpless operation and minimized bubble entrapment. The purpose of this paper is to describe the design and operation of a 14 chamber multi-organ system representing 13 tissues/organs with both barrier and nonbarrier tissue chambers and to study the interactive responses among the various cell lines. We demonstrate that five different cell lines survived with high viability (above 85%) for 7 days. We compared the individual observed flow rates to the compartments to the desired or estimated flow rates. This work demonstrates the feasibility of constructing, operating and maintaining a simple, gravity-driven, multi-organ microphysiological system with the capability of measuring cellular functions such as CYP1A1 and CYP3A4 activities, albumin release, urea, maintenance of tight junctions, and presence of surfactant for a sustained period. Biotechnol. Bioeng. 2016;113: 2213-2227.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  PBPK model; drug evaluation; human surrogates; microfabrication; microphysiological systems; tissue engineered models

Mesh:

Year:  2016        PMID: 27070809     DOI: 10.1002/bit.25989

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  58 in total

1.  Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips.

Authors:  Richard Novak; Meredyth Didier; Elizabeth Calamari; Carlos F Ng; Youngjae Choe; Susan L Clauson; Bret A Nestor; Jefferson Puerta; Rachel Fleming; Sasan J Firoozinezhad; Donald E Ingber
Journal:  J Vis Exp       Date:  2018-10-20       Impact factor: 1.355

Review 2.  Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models.

Authors:  Alexa Wnorowski; Huaxiao Yang; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2018-06-06       Impact factor: 15.470

3.  A pumpless body-on-a-chip model using a primary culture of human intestinal cells and a 3D culture of liver cells.

Authors:  Huanhuan Joyce Chen; Paula Miller; Michael L Shuler
Journal:  Lab Chip       Date:  2018-07-10       Impact factor: 6.799

4.  UniChip enables long-term recirculating unidirectional perfusion with gravity-driven flow for microphysiological systems.

Authors:  Ying I Wang; Michael L Shuler
Journal:  Lab Chip       Date:  2018-08-21       Impact factor: 6.799

Review 5.  Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.

Authors:  David J Hughes; Tomasz Kostrzewski; Emma L Sceats
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-15

6.  Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system.

Authors:  Carlota Oleaga; Anne Riu; Sandra Rothemund; Andrea Lavado; Christopher W McAleer; Christopher J Long; Keisha Persaud; Narasimhan Sriram Narasimhan; My Tran; Jeffry Roles; Carlos A Carmona-Moran; Trevor Sasserath; Daniel H Elbrecht; Lee Kumanchik; L Richard Bridges; Candace Martin; Mark T Schnepper; Gail Ekman; Max Jackson; Ying I Wang; Reine Note; Jessica Langer; Silvia Teissier; James J Hickman
Journal:  Biomaterials       Date:  2018-08-04       Impact factor: 12.479

Review 7.  Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.

Authors:  Ying I Wang; Carlos Carmona; James J Hickman; Michael L Shuler
Journal:  Adv Healthc Mater       Date:  2017-12-04       Impact factor: 9.933

Review 8.  Advances in microfluidic devices made from thermoplastics used in cell biology and analyses.

Authors:  Elif Gencturk; Senol Mutlu; Kutlu O Ulgen
Journal:  Biomicrofluidics       Date:  2017-10-24       Impact factor: 2.800

9.  Tissue engineering toward organ-specific regeneration and disease modeling.

Authors:  Christian Mandrycky; Kiet Phong; Ying Zheng
Journal:  MRS Commun       Date:  2017-07-31       Impact factor: 2.566

10.  Microphysiological Systems: Design, Fabrication, and Applications.

Authors:  Kai Wang; Kun Man; Jiafeng Liu; Yang Liu; Qi Chen; Yong Zhou; Yong Yang
Journal:  ACS Biomater Sci Eng       Date:  2020-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.